U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07560852) titled 'Impact of Endotest on Patients' Quality of Life: a Cohort Study' on April 08.
Brief Summary: Ziwig Endotest(R) ('Endotest') is marketed in several countries, including Switzerland, which was the first country to make it available in 2022. Since February 2025, several French clinical investigation sites have been offering Endotest, developed by Ziwig, under the innovation funding. Initially, this innovation funding enabled 2,500 patients to be included in a clinical trial (ENDOBEST: ID-RCB 2024-A02092-45). Since the end of December 2025, it has been expanded and now covers a further 22,500 patients whose are not included in the trial. ...